IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex

被引:1522
作者
Kotenko, SV [1 ]
Gallagher, G
Baurin, VV
Lewis-Antes, A
Shen, ML
Shah, NK
Langer, JA
Sheikh, F
Dickensheets, H
Donnelly, RP
机构
[1] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA
[2] Univ Med & Dent New Jersey, New Jersey Dent Sch, Dept Oral Biol, Newark, NJ 07103 USA
[3] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Microbiol Mol Genet & Immunol, Piscataway, NJ 08854 USA
[4] US FDA, Ctr Biol Evaluat & Res, Div Therapeut Prot, Bethesda, MD 20892 USA
关键词
D O I
10.1038/ni875
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We report here the identification of a ligand-receptor system that, upon engagement, leads to the establishment of an antiviral state. Three closely positioned genes on human chromosome 19 encode distinct but paralogous proteins, which we designate interferon-lambda1 (IFN-lambda1), IFN-lambda2 and IFN-lambda3 (tentatively designated as IL-29, IL- 28A and IL-28B, respectively, by HUGO). The expression of IFN-lambda mRNAs was inducible by viral infection in several cell lines. We identified a distinct receptor complex that is utilized by all three IFN-lambda proteins for signaling and is composed of two subunits, a receptor designated CRF2-12 (also designated as IFN-lambdaR1) and a second subunit, CRF2-4 (also known as IL-10R2). Both receptor chains are constitutively expressed on a wide variety of human cell lines and tissues and signal through the Jak-STAT (Janus kinases-signal transducers and activators of transcription) pathway. This receptor-ligand system may contribute to antiviral or other defenses by a mechanism similar to, but independent of, type I IFNs.
引用
收藏
页码:69 / 77
页数:9
相关论文
共 44 条
  • [1] Lack of a role for type I and type II interferons in the resolution of rotavirus-induced diarrhea and infection in mice
    Angel, J
    Franco, MA
    Greenberg, HB
    Bass, D
    [J]. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1999, 19 (06) : 655 - 659
  • [2] [Anonymous], [No title captured]
  • [3] PRODUCTION OF MONOCLONAL ANTIBODIES TO GROUP-A ERYTHROCYTES, HLA AND OTHER HUMAN CELL-SURFACE ANTIGENS - NEW TOOLS FOR GENETIC-ANALYSIS
    BARNSTABLE, CJ
    BODMER, WF
    BROWN, G
    GALFRE, G
    MILSTEIN, C
    WILLIAMS, AF
    ZIEGLER, A
    [J]. CELL, 1978, 14 (01) : 9 - 20
  • [4] Interferons α and β as immune regulators -: A new look
    Biron, CA
    [J]. IMMUNITY, 2001, 14 (06) : 661 - 664
  • [5] Interleukin 20: Discovery, receptor identification, and role in epidermal function
    Blumberg, H
    Conklin, D
    Xu, WF
    Grossmann, A
    Brender, T
    Carollo, S
    Eagan, M
    Foster, D
    Haldeman, BA
    Hammond, A
    Haugen, H
    Jelinek, L
    Kelly, JD
    Madden, K
    Maurer, MF
    Parrish-Novak, J
    Prunkard, D
    Sexson, S
    Sprecher, C
    Waggie, K
    West, J
    Whitmore, TE
    Yao, L
    Kuechle, MK
    Dale, BA
    Chandrasekher, YA
    [J]. CELL, 2001, 104 (01) : 9 - 19
  • [6] JAK-STAT PATHWAYS AND TRANSCRIPTIONAL ACTIVATION IN RESPONSE TO IFNS AND OTHER EXTRACELLULAR SIGNALING PROTEINS
    DARNELL, JE
    KERR, IM
    STARK, GR
    [J]. SCIENCE, 1994, 264 (5164) : 1415 - 1421
  • [7] Domanski Paul, 1996, Cytokine and Growth Factor Reviews, V7, P143, DOI 10.1016/1359-6101(96)00017-2
  • [8] Dumoutier L, 2002, EUR CYTOKINE NETW, V13, P5
  • [9] Familletti P C, 1981, Methods Enzymol, V78, P387
  • [10] The interleukin-10 family of cytokines
    Fickenscher, H
    Hör, S
    Küpers, H
    Knappe, A
    Wittmann, S
    Sticht, H
    [J]. TRENDS IN IMMUNOLOGY, 2002, 23 (02) : 89 - 96